BioXcel Therapeutics
BTAI
#9638
Rank
โ‚น1.80 B
Marketcap
โ‚น42.22
Share price
-12.36%
Change (1 day)
-87.01%
Change (1 year)

Revenue for BioXcel Therapeutics (BTAI)

Revenue in 2024 (TTM): โ‚น0.20 Billion

According to BioXcel Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น0.20 Billion. In 2023 the company made a revenue of โ‚น0.11 Billion an increase over the revenue in the year 2022 that were of โ‚น31.03 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioXcel Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น0.20 B74.29%
2023 โ‚น0.11 B270.22%
2022 โ‚น31.03 M
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA